Citation only
via Europe PMC
The Link between Gut Microbiome, Amyloid-Beta Deposition, Brain Inflammation, and Alzheimer's Disease: A Review of Current Literature.
Current neuropharmacology · 2026
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-beta (Aβ) plaques, neurofibrillary tangles, and cognitive decline. AD has gained increasing global attention. As the aging population continues to grow, the economic burden on individuals, families, and healthcare systems rises, emphasizing the urgent need for early detection and natural therapeutic approaches to address these challenges. The gut microbiota regulates essential physiological functions, including digestion, nutrient absorption, and inflammatory signaling. Dysbiosis, or changes in gut microbiome composition, is marked by the overgrowth of pathogenic bacteria and depletion of beneficial species. Gut dysbiosis is also linked to pathological features of AD, such as increased Aβ deposition, compromised intestinal and blood-brain barrier integrity, and neuroinflammation through the brain-gut microbiome axis (BGMA). However, the connection between the gut microbiome and AD pathological hallmarks remains unclear. This narrative review aims to explore current research on the relationship between gut dysbiosis and the pathological features of AD, with the goal of highlighting the role of the gut system in brain function and AD pathogenesis. Vitamin E, due to its antioxidative and anti-inflammatory properties, may serve as a promising natural option for modulating the gut microbiome while potentially delaying AD progression and promoting a balanced microbial composition.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.2174/011570159x416900251207210728
- Canonical
- link ↗
- Fetched
- 2026-07-01 MST
Cite this
APA
NI, E.A., & S., M. (2026). The Link between Gut Microbiome, Amyloid-Beta Deposition, Brain Inflammation, and Alzheimer's Disease: A Review of Current Literature. <em>Current neuropharmacology</em>. https://doi.org/10.2174/011570159x416900251207210728
Vancouver
NI EA, S. M. The Link between Gut Microbiome, Amyloid-Beta Deposition, Brain Inflammation, and Alzheimer's Disease: A Review of Current Literature. Current neuropharmacology. 2026. doi:10.2174/011570159x416900251207210728.
BibTeX
@article{ely2026TheLin,
title = {The Link between Gut Microbiome, Amyloid-Beta Deposition, Brain Inflammation, and Alzheimer's Disease: A Review of Current Literature.},
author = {Ely Arman NI and Makpol S.},
journal = {Current neuropharmacology},
year = {2026},
doi = {10.2174/011570159x416900251207210728},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Tissue Barriers 2017
Open access · OA
Intestinal barrier and gut microbiota: Shaping our immune responses throughout life
Sleep Medicine 2021
Open access · CC-BY
Relationship between sleep disorders and gut dysbiosis: what affects what?
Problems of Geroscience 2024
Open access · CC-BY
The gut microbiome as a central player in aging: mechanisms and health outcomes
Experimental Gerontology 2024
Open access · CC-BY
Influence of human gut microbiome on the healthy and the neurodegenerative aging
Frontiers in Cellular Neuroscience 2022
Open access · CC-BY
A review of the preclinical and clinical studies on the role of the gut microbiome in aging and neurodegenerative diseases and its modulation
Advances in Gerontology 2024
Citation only